CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2023

Dec 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2023-12-07

Reporting Person: Daly Richard J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-07	Common Stock, par value $0.001 per share	M	60000	$1.13	Acquired	208000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-07	Options to purchase common stock	$1.13	M	60000	Disposed	2017-01-03	Common Stock (60000)	Direct

Footnotes

F1: The option was granted on January 3, 2017 and previously vested in three annual installments.